
Please try another search
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical research organization services. In addition, the company builds a bridge between research/ development and healthcare markets, as well as support researchers and entrepreneurs in the positioning, structuring, development, and implementation of their ideas; and operates as an active ingredient manufacturer. Further, it focuses on identifying innovative biomarkers in the field of kidney diseases; the development of antibody-drug conjugates through a click chemistry approach and microfluidic screening of functional antibodies; and provides Neuromex, a screening instrument for the early-stage detection of neurological diseases. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.
Name | Age | Since | Title |
---|---|---|---|
Ernst Th. Rietschel | - | - | Member of the Advisory Board |
Christoph Brucher | - | - | Member of the Advisory Board |
Uwe Rudolf Max Reuter | - | - | Member of the Advisory Board |
Johannes Schumacher | - | - | Member of the Advisory Board |
Hans-Georg Rammensee | - | - | Member of the Advisory Board |
David L. Deck | - | 2022 | President of the Board of Directors |
Mark S. Muller | - | 2018 | Non-Executive Independent Director |
Ralf Oettmeier | - | - | Member of the Advisory Board |
Oliver R. Baumann | - | 2020 | CEO & Executive Director |
Jurgen Eckel | - | 2023 | Member of the Advisory Board |
Ulrich Rath | - | 2023 | Member of the Advisory Board |
Bernward Garthoff | - | 2023 | Member of the Advisory Board |
Desiree Dosch | - | 2022 | Independent Non-Executive Director |
Michael B. Klein | - | - | Chairman of Advisory Baord |
Norbert Windhab | - | 2022 | Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review